Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 3
2006 5
2007 5
2009 3
2010 5
2011 4
2012 2
2013 5
2014 5
2015 4
2016 1
2018 2
2019 3
2020 3
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alexander v togo[Author] (1 results)?
Evidence against involvement of p53 polymorphism in breast cancer predisposition.
Suspitsin EN, Buslov KG, Grigoriev MY, Ishutkina JG, Ulibina JM, Gorodinskaya VM, Pozharisski KM, Berstein LM, Hanson KP, Togo AV, Imyanitov EN. Suspitsin EN, et al. Among authors: togo av. Int J Cancer. 2003 Jan 20;103(3):431-3. doi: 10.1002/ijc.10834. Int J Cancer. 2003. PMID: 12471629 Free article. Review. No abstract available.
Frequency and molecular characteristics of PALB2-associated cancers in Russian patients.
Preobrazhenskaya EV, Shleykina AU, Gorustovich OA, Martianov AS, Bizin IV, Anisimova EI, Sokolova TN, Chuinyshena SA, Kuligina ES, Togo AV, Belyaev AM, Ivantsov AO, Sokolenko AP, Imyanitov EN. Preobrazhenskaya EV, et al. Among authors: togo av. Int J Cancer. 2021 Jan 1;148(1):203-210. doi: 10.1002/ijc.33317. Epub 2020 Oct 6. Int J Cancer. 2021. PMID: 32997802 Free article.
Novel ALK fusion partners in lung cancer.
Iyevleva AG, Raskin GA, Tiurin VI, Sokolenko AP, Mitiushkina NV, Aleksakhina SN, Garifullina AR, Strelkova TN, Merkulov VO, Ivantsov AO, Kuligina ESh, Pozharisski KM, Togo AV, Imyanitov EN. Iyevleva AG, et al. Among authors: togo av. Cancer Lett. 2015 Jun 28;362(1):116-21. doi: 10.1016/j.canlet.2015.03.028. Epub 2015 Mar 23. Cancer Lett. 2015. PMID: 25813404
The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
Yanus GA, Akhapkina TA, Iyevleva AG, Kornilov AV, Suspitsin EN, Kuligina ES, Ivantsov AO, Aleksakhina SN, Sokolova TN, Sokolenko AP, Togo AV, Imyanitov EN. Yanus GA, et al. Among authors: togo av. Eur J Med Genet. 2020 Mar;63(3):103753. doi: 10.1016/j.ejmg.2019.103753. Epub 2019 Sep 3. Eur J Med Genet. 2020. PMID: 31491536
Exome-based search for recurrent disease-causing alleles in Russian population.
Yanus GA, Akhapkina TA, Whitehead AJ, Bizin IV, Iyevleva AG, Kuligina ES, Aleksakhina SN, Anisimova MO, Holmatov MM, Romanko AA, Zaitseva OA, Yatsuk OS, Zagorodnev KA, Matsneva MA, Koloskov AV, Togo AV, Suspitsin EN, Imyanitov EN. Yanus GA, et al. Among authors: togo av. Eur J Med Genet. 2019 Jul;62(7):103656. doi: 10.1016/j.ejmg.2019.04.013. Epub 2019 Apr 24. Eur J Med Genet. 2019. PMID: 31028847
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.
Iyevleva AG, Aleksakhina SN, Sokolenko AP, Baskina SV, Venina AR, Anisimova EI, Bizin IV, Ivantsov AO, Belysheva YV, Chernyakova AP, Togo AV, Imyanitov EN. Iyevleva AG, et al. Among authors: togo av. Breast Cancer Res Treat. 2022 Apr;192(2):283-291. doi: 10.1007/s10549-022-06517-3. Epub 2022 Jan 12. Breast Cancer Res Treat. 2022. PMID: 35020107
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.
Moiseyenko VM, Moiseyenko FV, Yanus GA, Kuligina ES, Sokolenko AP, Bizin IV, Kudriavtsev AA, Aleksakhina SN, Volkov NM, Chubenko VA, Kozyreva KS, Kramchaninov MM, Zhuravlev AS, Shelekhova KV, Pashkov DV, Ivantsov AO, Venina AR, Sokolova TN, Preobrazhenskaya EV, Mitiushkina NV, Togo AV, Iyevleva AG, Imyanitov EN. Moiseyenko VM, et al. Among authors: togo av. Clin Drug Investig. 2018 Jun;38(6):553-562. doi: 10.1007/s40261-018-0629-1. Clin Drug Investig. 2018. PMID: 29470838
High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.
Sokolenko AP, Bulanova DR, Iyevleva AG, Aleksakhina SN, Preobrazhenskaya EV, Ivantsov AO, Kuligina ESh, Mitiushkina NV, Suspitsin EN, Yanus GA, Zaitseva OA, Yatsuk OS, Togo AV, Kota P, Dixon JM, Larionov AA, Kuznetsov SG, Imyanitov EN. Sokolenko AP, et al. Among authors: togo av. Int J Cancer. 2014 May 15;134(10):2352-8. doi: 10.1002/ijc.28569. Epub 2014 Jan 27. Int J Cancer. 2014. PMID: 24470238 Free article.
Non-founder BRCA1 mutations in Russian breast cancer patients.
Iyevleva AG, Suspitsin EN, Kroeze K, Gorodnova TV, Sokolenko AP, Buslov KG, Voskresenskiy DA, Togo AV, Kovalenko SP, Stoep Nv, Devilee P, Imyanitov EN. Iyevleva AG, et al. Among authors: togo av. Cancer Lett. 2010 Dec 8;298(2):258-63. doi: 10.1016/j.canlet.2010.07.013. Epub 2010 Aug 19. Cancer Lett. 2010. PMID: 20727672
54 results